Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Deep Vein Thrombosis Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.
An extensive global market report on Deep Vein Thrombosis (DVT), offering a detailed analysis and comprehensive insights, has been recently added to a leading industry research repository. The report presents an in-depth study of the current state and future prospects of the DVT market, which is anticipated to witness a significant growth trajectory.
According to the research, the deep vein thrombosis market, previously valued at $1.03 billion in 2023, is expected to rise to a value of $1.07 billion in 2024. This projects a Compound Annual Growth Rate (CAGR) of 4.5% during the period. By 2028, the market is forecasted to reach a valuation of $1.26 billion with a steady CAGR of 4.1%. The report elucidates driving factors such as increased awareness, the emergence of specialized vascular medicine, and advancements in diagnostic and treatment methods contributing to market growth.
Innovations in the deep vein thrombosis sector are spotlighted within the report. The advent of cutting-edge mechanical thrombectomy systems, such as the Lightning Flash from Penumbra Inc., pioneers new horizons in DVT treatment efficiency and safety, creating a positive impact on the market landscape.
Key Drivers and Trends in the DVT Market
- The aging population and a rise in lifestyle-related diseases are pivotal in propelling the market forward.
- Obesity's prevalence, posing heightened risk for venous thromboembolism, emphasizes the need for effective DVT treatments.
- Technological advancements and AI integration are shaping innovation in DVT diagnostics and treatment approaches.
- Strategic partnerships and trials, such as the ThinkSono Guidance System trial, endorse AI's role in advancing DVT diagnosis accuracy.
The report encompasses a comprehensive analysis of geographic regions, with North America leading the market in 2023 and Asia-Pacific projected as the fastest-growing region. Detailed insights into the market dynamics across different areas, including Western Europe, Eastern Europe, South America, the Middle East, and Africa, shed light on global trends and opportunities.
Market Segmentation and Key Therapeutic Categories
Segmentation in the deep vein thrombosis market report spans drugs types such as anticoagulants and inferior vena cava filters, alongside various treatment approaches and distribution channels. The report identifies key therapeutic interventions and aligns them with market demands reflecting their adoption across hospitals, specialty clinics, and homecare settings.
The deep vein thrombosis market research report stands as a testament to the industry's commitment to understanding the evolving landscape of DVT treatments. It offers market players robust statistics and targeted analyses to navigate this dynamic healthcare sector effectively.
For media inquiries and more information regarding the deep vein thrombosis market analysis, please refer to the full market research report.
A selection of companies mentioned in this report includes
- Abbott Laboratories
- Bristol-Myers Squibb Company
- Sanofi-Aventis U.S. LLC
- Daiichi Sankyo Company Limited
- Aspen Pharmacare Holdings Limited
- Novartis AG
- Mylan N.V.
- Bayer AG
- Boehringer Ingelheim GmbH
- Medtronic PLC
- Momenta Pharmaceuticals Inc.
- Hikma Pharmaceuticals PLC
- Laboratorios Farmacéuticos Rovi S.A.
- Cardinal Health Inc.
- Altimed Ltd.
- Teva Pharmaceutical Industries Ltd.
- Swiss Pharma Private Limited
- Laurus Labs Limited
- AstraZeneca PLC
- Stryker Corporation
- Cook Medical Incorporated
- Boston Scientific Corporation
- Koninklijke Philips N.V.
- Arjo AB
- DJO Global Inc.
- Zimmer Biomet Holdings Inc.
- Devon Medical Products LLC
- ThermoTek USA Inc.
- Lonza Group AG
- Pfizer Inc.
For more information about this report visit https://www.researchandmarkets.com/r/fcirup
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
